Cargando…
A Predictive Model for Toxicity Effects Assessment of Biotransformed Hepatic Drugs Using Iterative Sampling Method
Measuring toxicity is one of the main steps in drug development. Hence, there is a high demand for computational models to predict the toxicity effects of the potential drugs. In this study, we used a dataset, which consists of four toxicity effects:mutagenic, tumorigenic, irritant and reproductive...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146749/ https://www.ncbi.nlm.nih.gov/pubmed/27934950 http://dx.doi.org/10.1038/srep38660 |
_version_ | 1782473542581878784 |
---|---|
author | Tharwat, Alaa Moemen, Yasmine S. Hassanien, Aboul Ella |
author_facet | Tharwat, Alaa Moemen, Yasmine S. Hassanien, Aboul Ella |
author_sort | Tharwat, Alaa |
collection | PubMed |
description | Measuring toxicity is one of the main steps in drug development. Hence, there is a high demand for computational models to predict the toxicity effects of the potential drugs. In this study, we used a dataset, which consists of four toxicity effects:mutagenic, tumorigenic, irritant and reproductive effects. The proposed model consists of three phases. In the first phase, rough set-based methods are used to select the most discriminative features for reducing the classification time and improving the classification performance. Due to the imbalanced class distribution, in the second phase, different sampling methods such as Random Under-Sampling, Random Over-Sampling and Synthetic Minority Oversampling Technique are used to solve the problem of imbalanced datasets. ITerative Sampling (ITS) method is proposed to avoid the limitations of those methods. ITS method has two steps. The first step (sampling step) iteratively modifies the prior distribution of the minority and majority classes. In the second step, a data cleaning method is used to remove the overlapping that is produced from the first step. In the third phase, Bagging classifier is used to classify an unknown drug into toxic or non-toxic. The experimental results proved that the proposed model performed well in classifying the unknown samples according to all toxic effects in the imbalanced datasets. |
format | Online Article Text |
id | pubmed-5146749 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-51467492016-12-16 A Predictive Model for Toxicity Effects Assessment of Biotransformed Hepatic Drugs Using Iterative Sampling Method Tharwat, Alaa Moemen, Yasmine S. Hassanien, Aboul Ella Sci Rep Article Measuring toxicity is one of the main steps in drug development. Hence, there is a high demand for computational models to predict the toxicity effects of the potential drugs. In this study, we used a dataset, which consists of four toxicity effects:mutagenic, tumorigenic, irritant and reproductive effects. The proposed model consists of three phases. In the first phase, rough set-based methods are used to select the most discriminative features for reducing the classification time and improving the classification performance. Due to the imbalanced class distribution, in the second phase, different sampling methods such as Random Under-Sampling, Random Over-Sampling and Synthetic Minority Oversampling Technique are used to solve the problem of imbalanced datasets. ITerative Sampling (ITS) method is proposed to avoid the limitations of those methods. ITS method has two steps. The first step (sampling step) iteratively modifies the prior distribution of the minority and majority classes. In the second step, a data cleaning method is used to remove the overlapping that is produced from the first step. In the third phase, Bagging classifier is used to classify an unknown drug into toxic or non-toxic. The experimental results proved that the proposed model performed well in classifying the unknown samples according to all toxic effects in the imbalanced datasets. Nature Publishing Group 2016-12-09 /pmc/articles/PMC5146749/ /pubmed/27934950 http://dx.doi.org/10.1038/srep38660 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Tharwat, Alaa Moemen, Yasmine S. Hassanien, Aboul Ella A Predictive Model for Toxicity Effects Assessment of Biotransformed Hepatic Drugs Using Iterative Sampling Method |
title | A Predictive Model for Toxicity Effects Assessment of Biotransformed Hepatic Drugs Using Iterative Sampling Method |
title_full | A Predictive Model for Toxicity Effects Assessment of Biotransformed Hepatic Drugs Using Iterative Sampling Method |
title_fullStr | A Predictive Model for Toxicity Effects Assessment of Biotransformed Hepatic Drugs Using Iterative Sampling Method |
title_full_unstemmed | A Predictive Model for Toxicity Effects Assessment of Biotransformed Hepatic Drugs Using Iterative Sampling Method |
title_short | A Predictive Model for Toxicity Effects Assessment of Biotransformed Hepatic Drugs Using Iterative Sampling Method |
title_sort | predictive model for toxicity effects assessment of biotransformed hepatic drugs using iterative sampling method |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146749/ https://www.ncbi.nlm.nih.gov/pubmed/27934950 http://dx.doi.org/10.1038/srep38660 |
work_keys_str_mv | AT tharwatalaa apredictivemodelfortoxicityeffectsassessmentofbiotransformedhepaticdrugsusingiterativesamplingmethod AT moemenyasmines apredictivemodelfortoxicityeffectsassessmentofbiotransformedhepaticdrugsusingiterativesamplingmethod AT hassanienaboulella apredictivemodelfortoxicityeffectsassessmentofbiotransformedhepaticdrugsusingiterativesamplingmethod AT tharwatalaa predictivemodelfortoxicityeffectsassessmentofbiotransformedhepaticdrugsusingiterativesamplingmethod AT moemenyasmines predictivemodelfortoxicityeffectsassessmentofbiotransformedhepaticdrugsusingiterativesamplingmethod AT hassanienaboulella predictivemodelfortoxicityeffectsassessmentofbiotransformedhepaticdrugsusingiterativesamplingmethod |